BostonGene Stock
BostonGene is a biotechnology company focused on advancing personalized medicine and precision oncology. The company leverages artificial intelligence (AI) and genomics to provide insights into the molecular profile of cancer, helping to identify the most effective treatments for individual patients.
Sign up for SecondMarket™ to view the market and buy or sell BostonGene Stock
Buy + SellBostonGene Funding
Sign up to gain insights into BostonGene funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Apr 06, 2022 | Series B | 150.00M | ||
| Apr 25, 2019 | Series A | 50.00M |
See BostonGene Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into BostonGene Stock Valuation + Share Prices
View real-time Tape D™ data on BostonGene stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
BostonGene Management Team
Chief Medical Officer
Nathan Fowler
Director
Takayuki Morita
Director
Ned Segal
President, CEO, Director
Andrew Feinberg
Director
Michael Feinberg
Chief Scientific Officer
Joe Lennerz
Chief Product Officer
Alexander Bagaev
BostonGene Major Investors
Japan Industrial Partners
NEC Corporation
Impact Investment Capital
Learn More About BostonGene Stock
Buy BostonGene Stock
01BostonGene stock does not trade on public stock exchanges. BostonGene stock is considered a private security and you need to be an accredited investor to trade shares. To invest in BostonGene stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell BostonGene Stock
02BostonGene Stock does not trade on public stock exchanges. In order to sell BostonGene shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
BostonGene Stock Price
03BostonGene does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view BostonGene share price and other valuable private market data.
Read more about secondary market private company stock prices:
BostonGene Stock Ticker Symbol
04There is no ticker symbol for BostonGene stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell BostonGene Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell BostonGene stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in BostonGene Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in BostonGene stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
BostonGene Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
BostonGene IPO
08BostonGene is a private company and has not had an IPO. There is currently no BostonGene IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to BostonGene IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell BostonGene Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
